#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Netherton's syndrome Choroidal dystrophy Pulmonary alveolar haemorrhage Familial dilated cardiomyopathy Cutaneous lupus erythematosus Langerhans' cell histiocytosis Anti-HLA antibody test positive Canavan disease Pulmonary sarcoidosis Kidney transplant rejection Alport's syndrome Retinopathy proliferative Hodgkin's disease Neuroblastoma Astrocytoma malignant More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Diagnostics Mantle cell lymphoma refractory – Life with Disease Congenital generalised lipodystrophy – Diagnostics Ornithine transcarbamoylase deficiency – Diagnostics Cholangitis sclerosing Primary immunodeficiency syndrome – Trials in Disease Ewing’s sarcoma recurrent – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Focal segmental glomerulosclerosis Acute respiratory distress syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    S095035 Oxitriptan Dasatinib Mk-4830 Methylprednisolone Aceponate Bi 1015550 Diacerein Tulmimetostat Talquetamab Canakinumab Opevesostat Tosilate Zibotentan GSKVX000000030810 Copper (64Cu) Chloride Relacorilant Aavanc80-5'Hotof Flutafuranol (18F) Contezolid Avatrombopag Cart 19/22 T Cells More therapies…

    Learn about Your Condition

    Becker's muscular dystrophy Connective tissue disorder Giardiasis Frontotemporal dementia Dyskinesia Albuminuria Niemann-Pick disease Cryoglobulinaemia Muscle spasticity Dyspepsia Von Hippel-Lindau disease Univentricular heart Hand fracture Endocarditis enterococcal Naevus flammeus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Levoleucovorin
    • Levoleucovorin Disodium
    • Fluorouracil
    Belgium

  • Study on Long-Term Use of Infigratinib for Children with Achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    France Italy Norway Spain

  • Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Tetracosactide
    • Fluticasone Propionate
    The Netherlands

  • Study on [18F]Fluoro-PEG-Folate Imaging for Patients with Giant Cell Arteritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • [18F]Fluoro-Peg-Folate
    The Netherlands

  • Study on the Safety and Effectiveness of Teclistamab and Talquetamab for Patients with Newly Diagnosed Multiple Myeloma Eligible for Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Betamethasone Sodium Phosphate
    • Teclistamab
    Germany

  • Study on Brachial Plexus Nerve Block with Epinephrine and Lidocaine for Adults with Distal Radius Fracture Needing Closed Reduction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Radius fracture
    Investigated Drugs:
    • Epinephrine
    • Lidocaine Hydrochloride
    Denmark
Previous Page
1 … 364 365 366 367 368 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!